Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.5, 2000-07, pp. : 1007-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach

By Dransfield Mark T Bailey William C

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 13-25

Informa Healthcare

Access to resources Recommend Favorite

Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation

By Patel Manish Thomson Neil C

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1069-1075

Informa Healthcare

Access to resources Recommend Favorite

Acute Exacerbations in Chronic Obstructive Pulmonary Disease: Current Strategies with Pharmacological Therapy

By Hall C.S. Kyprianou A. Fein A.M.

Drugs, Vol. 63, Iss. 14, 2003-01 ,pp. : 1481-1488

Adis International

Access to resources Recommend Favorite

A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease

By Menn Petra Leidl Reiner Holle Rolf

PharmacoEconomics, Vol. 30, Iss. 9, 2012-09 ,pp. : 825-840

Adis International

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite